119 results
Page 5 of 6
8-K
EX-10.1
9yvdc
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
8-K
EX-99.1
4vzt5s9wuow9gf
11 May 20
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
4:38pm
8-K
EX-99.1
m8cw6ue se28
26 Mar 20
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
7:39am
424B5
ea4bp9
20 Mar 20
Prospectus supplement for primary offering
8:26am
8-K
EX-99.1
e30pnb qxx6tk
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-10.1
ypaxz8rtcfl7v ehaf
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-10.2
i4dqyga8tl8u 982yhof
20 Mar 20
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25
7:40am
8-K
EX-99.1
9b6zm2qgmmb w07v2l38
2 Mar 20
Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers
8:50am
8-K
EX-99.1
9uwrc6e2a
29 Jan 20
Other Events
7:13am
8-K
EX-99.1
lysxz9qs05xio
9 Dec 19
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
7:00am
8-K
EX-99.1
429gz998k5 kyxospx
12 Nov 19
Unum Therapeutics Reports Third Quarter 2019 Financial Results
4:36pm
8-K
EX-99.1
lx9hl5 45
5 Nov 19
Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
2:16pm
8-K
EX-99.1
c6rx122n
4 Nov 19
Unum Therapeutics Announces Strategic Focus on DevelopingBest-in-Class
4:13pm
8-K
EX-99.1
tpk227p2 dihr0
12 Aug 19
Unum Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm